SCHEMBL4210293

SCHEMBL4210293

CC/C=C/C#CCCCC

nearest known ligand 0.46

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
HMGCR P04035 5/20 0.46
TSHR P16473 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4210295 1.00 HMGCR (0.46) HMGCRTSHR
SCHEMBL7710791 0.91 HMGCR (0.56) HMGCRTSHR
SCHEMBL7710793 0.91 HMGCR (0.56) HMGCRTSHR
SCHEMBL28737465 0.85
SCHEMBL9454165 0.82 HMGCR (0.44) HMGCRTSHR
SCHEMBL9454173 0.82 HMGCR (0.44) HMGCRTSHR
SCHEMBL16161662 0.80 HMGCR (0.39) HMGCRTSHR
SCHEMBL16161131 0.80 HMGCR (0.39) HMGCR
SCHEMBL16161661 0.80 HMGCR (0.39) HMGCRTSHR
SCHEMBL16161132 0.80 HMGCR (0.39) HMGCR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090069569-A1 CYCLOADDITION OF AZIDES AND ALKYNES INSTITUT CATALA D'INVESTIGACIO QUIMICA (ES) 2009-03-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090069569-A1 CYCLOADDITION OF AZIDES AND ALKYNES PF4, AFF4, FLI1 HMGCR 4771/4885TSHR 860/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.